March 17 (Reuters) - VALBIOTIS SA ALVAL.PA :
* FY REVENUE 3.092 MILLION EUR
* EUR 14.6M IN CASH AS AT DECEMBER 31, 2020
* IN 2020, VALBIOTIS GENERATED A TURNOVER OF EUR 3,092K
* FY NET LOSS EUR 3.8 MILLION VERSUS LOSS OF EUR 5.5 MILLION
YEAR
AGO
* A SERIES OF PRECLINICAL EXPERIMENTS WILL ALSO BE LAUNCHED
AND
COMPLETED IN 2021: STUDIES SHOULD PROVIDE FURTHER DETAILS ON
IMPACT OF TOTUM-070 ON LIPID METABOLISM IN A PREDICTIVE MODEL OF
HUMAN PATHOPHYSIOLOGY
* FY OPERATING LOSS EUR 3.4 MILLION VERSUS LOSS OF EUR 5.2
MILLION
YEAR AGO
Source text for Eikon: ID:nBwQqxHFa
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))